not logged in

European Urology

European Urology

Volume 58, issue 2, pages e19-e28, August 2010

Case Study of the Month

Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma eulogo1

Oscar Rodríguez Faba, Alberto Breda, Antonio Rosales, Joan Palou, Ferran Algaba, Pablo Maroto Rey and Humberto Villavicencio

Accepted 3 March 2010, Published online 12 March 2010, pages 307 - 310


EU-ACME question

Please visit www.eu-acme.org/europeanurology to answer the following EU-ACME question online (the EU-ACME credits will be attributed automatically).
Question:
What are the options for the management of metastatic non–clear cell renal cell carcinoma?

  • A. Neoadjuvant treatment with temsirolimus, sunitinib, sorafenib.
  • B. Chemotherapy.
  • C. Immunotherapy.
  • D. Radical nephrectomy.

Recommend this article

Currently this article has a rating of 0. Please log in to recommend it.

Articles in this new format: